Medlera Cardiac CKMB Rapid Test

Medlera CK-MB Rapid Test is a rapid immunochromatographic assay for the qualitative detection of human CK-MB in whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI).

Category:

Description

01. Accurate Diagnosis:

Ability to accurately diagnose elevated levels of Creatine Kinase MB (CKMB), a key cardiac marker.

02. Auxiliary Diagnosis:

Helps in auxiliary diagnosis of myocardial infarction (MI), providing valuable insights into cardiac health.

03. Dual Colour Detection:

World’s first Dual colour detection technology tailored for the Creatine kinase-MB antigen (CKMB), enhancing detection accuracy.

04. Easy Interpretation:

Easy interpretation with RED test line, ensuring user-friendly and clear result understanding.

05. Faster Clearance:

Faster and clearer background clearance, streamlining the testing process.

06. Rapid Results:

Interpret results in 15 minutes, providing quick and actionable information for timely decision-making.

07. High Sensitivity:

Sensitivity of 5 ng/mL, enabling the detection of CKMB at low concentrations.

08. High Specificity:

Sensitivity: >99.00%, Specificity: >99.80%, ensuring reliable and precise results.

Additional information

What is detected

Creatine kinase-MB antigen (CKMB).

Its function

Aid in management and monitoring of Myocardial Infarction (MI) in human.

The type of specimen required

Human whole blood, serum, plasma samples.

The intended user

Professional Technical Person.

Sensitivity of Test

100%

Specificity of Test

100%